COLORECTAL CANCER METASTATIC
Clinical trials for COLORECTAL CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new COLORECTAL CANCER METASTATIC trials appear
Sign up with your email to follow new studies for COLORECTAL CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a common gut drug keep colorectal cancer at bay?
Disease control Not yet recruitingThis study tests whether adding lubiprostone, a drug used for constipation, to standard maintenance therapy can delay cancer recurrence in 124 adults with colorectal cancer that has spread to the lining of the abdomen. Participants have already had surgery to remove visible tumor…
Matched conditions: COLORECTAL CANCER METASTATIC
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New hope for Hard-to-Treat colorectal cancer: Triple-Drug combo targets liver tumors
Disease control Not yet recruitingThis study tests a combination of three drugs (balstilimab, botensilimab, and agenT-797) in adults with a type of colorectal cancer that has spread to the liver and hasn't responded to prior treatments. The goal is to see if the combination can shrink tumors and what side effects…
Matched conditions: COLORECTAL CANCER METASTATIC
Phase: PHASE2 • Sponsor: Darren Sigal, MD • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
Triple attack: virus therapy plus two drugs targets Hard-to-Treat liver metastases
Disease control Not yet recruitingThis early-stage study tests a new treatment for people with colorectal cancer that has spread to the liver and hasn't responded to standard therapies. The treatment combines a modified virus (BioTTT001) that targets cancer cells with two drugs (toripalimab and regorafenib) to bo…
Matched conditions: COLORECTAL CANCER METASTATIC
Phase: PHASE1 • Sponsor: China Medical University, China • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
Could a poop pill boost cancer treatment? new trial tests gut bacteria transplant for stubborn colorectal cancer
Disease control Not yet recruitingThis early-stage study tests whether transplanting gut bacteria from young donors (fecal microbiota transplant) can make immunotherapy and chemotherapy work better for people with a hard-to-treat type of metastatic colorectal cancer (MSS mCRC). Ten patients aged 18-75 who have al…
Matched conditions: COLORECTAL CANCER METASTATIC
Phase: EARLY_PHASE1 • Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Disease control
Last updated May 11, 2026 20:39 UTC